Clinical Rhinology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  15 (2024)
Volume  14 (2023)
Volume  13 (2020)
Volume  12 (2019)
Volume  11 (2018)
Volume  10 (2017)
Volume  9 (2016)
Volume  8 (2015)
Volume  7 (2014)
Volume  6 (2013)
Volume  5 (2012)
Volume  4 (2011)
Volume  3 (2010)
Volume  2 (2009)
Related articles

VOLUME 15 , ISSUE 1 ( January-April, 2024 ) > List of Articles

REVIEW ARTICLE

COVID-19 from an Otorhinolaryngologist Perspective in India: A Systematic Review

Chultim D Bhutia, Dolly Talda, Akshat Pandey, Anshuman Singh, Sushil Kumar Aggarwal

Keywords : Coronavirus disease-2019, Coronavirus, Otolaryngologist, Pandemic

Citation Information : Bhutia CD, Talda D, Pandey A, Singh A, Aggarwal SK. COVID-19 from an Otorhinolaryngologist Perspective in India: A Systematic Review. Clin Rhinol An Int J 2024; 15 (1):30-36.

DOI: 10.5005/jp-journals-10013-1394

License: CC BY-NC 4.0

Published Online: 16-11-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Here, we review the most recent findings on the effects of coronavirus disease-2019 (COVID-19) pandemic on the work of otolaryngologists. The clinical symptoms related and impact of the infection on the ear nose and throat examination and surgeries is summarized in this review. Otolaryngologists are at much higher risk for contracting the disease due to the close contact with mucous membranes of the upper respiratory tract and they have been among the most affected healthcare workers in Wuhan, China as per the previous studies. In this literature review, we have discussed the role of an otolaryngologist in detail in this COVID-19 pandemic. To write this review, an extensive search and analysis of the literature was done based on role of otorhinolaryngologists in dealing with COVID-19 and its complications.

PDF Share
  1. Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): Emerging and future challenges for dental and oral medicine. J Dent Res 2020; 99(5):481–487. DOI: 10.1177/0022034520914246.
  2. Chan KW, Wong VT, Tang SCW. COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese Western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med 2020:1–26. DOI: 10.1142/S0192415X20500378.
  3. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727–733. DOI: 10.1056/NEJMoa2001017.
  4. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018;23(2):130–137. DOI: 10.1111/resp.13196.
  5. Zhou P, Yang XL, Wang XG, et al. Pneumonia out-break associated with a new corona virus of probable bat origin. Nature 2020; 579(7798):270–273. DOI: 10.1038/s41586-020-2012-7.
  6. de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14(8):523–534. DOI: 10.1038/nrmicro.2016.81.
  7. Song Z, Xu Y, Bao L, et al. From SARS to MERS, thrusting corona viruses into the spotlight. Viruses 2019;11(1):59. DOI: 10.3390/v11010059.
  8. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020;323(18):1843–1844. DOI: 10.1001/jama.2020.3786.
  9. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382(12):1177–1179. DOI: 10.1056/NEJMc2001737.
  10. Chen J, Qi T, Liu L, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect 2020;80(5):e1–e6. DOI: 10.1016/j.jinf.2020.03.004.
  11. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648.
  12. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
  13. Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: Report of a case. Acta Neurol Taiwan 2006;15(1):26–28. PMID: 16599281.
  14. Akerlund A, Bende M, Murphy C. Olfactory threshold and nasal mucosal changes in experimentally induced common cold. Acta Otolaryngol 1995;115(1):88–92. DOI: 10.3109/00016489509133353.
  15. London B, Nabet B, Fisher AR, et al. Predictors of prognosis in patients with olfactory disturbance. Ann Neurol 2008;63(2):159–166. DOI: 10.1002/ana.21293.
  16. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):683–690. DOI: 10.1001/jamaneurol.2020.1127.
  17. Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe 2013;13(4):379–393. DOI: 10.1016/j.chom.2013.03.010.
  18. Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82(15):7264–7275. DOI: 10.1128/JVI.00737-08.
  19. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.
  20. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020;92(4): 401–402. DOI: 10.1002/jmv.25678.
  21. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395(10223):507–513. DOI: 10.1016/S0140-6736(20)30211-7.
  22. Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect 2020;53(3):365–367. DOI: 10.1016/j.jmii.2020.02.001.
  23. Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes. Emerg Microbes Infect 2020;9(1):386–389. DOI: 10.1080/22221751.2020.1729071.
  24. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. DOI: 10.1056/NEJMoa2002032.
  25. Chowell G, Abdirizak F, Lee S, et al. Transmission characteristics of MERS and SARS in the healthcare setting: A comparative study. BMC Med 2015;13:210. DOI: 10.1186/s12916-015-0450-0.
  26. Kang CK, Song KH, Choe PG, et al. Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. J Korean Med Sci 2017;32(5):744–749. DOI: 10.3346/jkms.2017.32.5.744.
  27. Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology 2016;56(1):1–30. DOI: 10.4193/Rhino 16.248.
  28. Gudziol H, Guntinas-Lichius O. Electrophysiologic assessment of olfactory and gustatory function. Handb Clin Neurol 2019;164:247–262. DOI: 10.1016/B978-0-444-63855-7.00016-2.
  29. Yamagishi M, Fujiwara M, Nakamura H. Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology 1994;32(3):113–118. PMID: 7530857.
  30. Holbrook EH, Leopold DA, Schwob JE. Abnormalities of axon growth in human olfactory mucosa. Laryngoscope 2005;115(12):2144–2154. DOI: 10.1097/01.MLG.0000181493.83661.CE.
  31. Holbrook EH, Rebeiz L, Schwob JE. Office-based olfactory mucosa biopsies. Int Forum Allergy Rhinol 2016;6(6):646–653. DOI: 10.1002/alr.21711.
  32. Schwob JE, Saha S, Youngentob SL, et al. Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice. Chem Senses 2001;26(8):937–952. DOI: 10.1093/chemse/26.8.937.
  33. Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 2020;6(31):eabc5801. DOI: 10.1126/sciadv.abc5801.
  34. Maxwell DN, Perl TM, Cutrell JB. “The Art of War” in the Era of Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 2020;71(16):2215–2217. DOI: 10.1093/cid/ciaa229.
  35. Li T. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: An operational recommendation of Peking Union Medical College Hospital (V2.0). Emerg Microbes Infect 2020;9(1):582–585. DOI: 10.1080/22221751.2020.1735265.
  36. Koh D. Occupational risks for COVID-19 infection. Occup Med (Lond) 2020;70(1):3–5. DOI: 10.1093/occmed/kqaa036.
  37. Ran L, Chen X, Wang Y, et al. Risk factors of healthcare workers with corona virus disease 2019: A retrospective cohort study in a designated hospital of Wuhan in China. Clin Infect Dis 2020;71(16): 2218–2221. DOI: 10.1093/cid/ciaa287.
  38. Lai THT, Tang EWH, Chau SKY, et al. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: An experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol 2020;258(5):1049–1055. DOI: 10.1007/s00417-020-04641-8.
  39. Lu D, Wang H, Yu R, et al. Integrated infection control strategy to minimize nosocomial infection of coronavirus disease 2019 among ENT healthcare workers. J Hosp Infect 2020;104(4):454–455. DOI: 10.1016/j.jhin.2020.02.018.
  40. Joob B, Wiwanitkit V. COVID-19 in medical personnel: Observation from Thailand. J Hosp Infect 2020;104(4):453. DOI: 10.1016/j.jhin.2020.02.016.
  41. Patel Z, Fernandez-Miranda J, Hwang P, et al. Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic 2020;87(1):E66–E67. DOI: 10.1093/neuros/nyaa125.
  42. Wahidi MM, Lamb C, Murgu S, et al. American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection. J Bronchology Interv Pulmonol 2020;27(4):e52–e54. DOI: 10.1097/LBR.0000000000000681.
  43. Wong J, Goh QY, Tan Z, et al. Preparing for a COVID-19 pandemic: A review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth 2020;67(6):732–745. DOI: 10.1007/s12630-020-01620-9.
  44. Ti LK, Ang LS, Foong TW, et al. What we do when a COVID-19 patient needs an operation: Operating room preparation and guidance. Can J Anaesth 2020;67(6):756–758. DOI: 10.1007/s12630-020-01617-4.
  45. American Academy of Otolaryngology Head and Neck Surgery (AAO-HNS). New Recommendations Regarding Urgent and Nonurgent Patient Care. 2020, March 22.
  46. Chee VW, Khoo ML, Lee SF, et al. Infection control measures for operative procedures in severe acute respiratory syndrome-related patients. Anesthesiology 2004;100(6):1394–1398. DOI: 10.1097/00000542-200406000-00010.
  47. Wei WI, Tuen HH, Ng RW, et al. Safe tracheostomy for patients with severe acute respiratory syndrome. Laryngoscope 2003;113(10):1777–1779. DOI: 10.1097/00005537-200310000-00022.
  48. Ahmed N, Hare GM, Merkley J, et al. Open tracheostomy in a suspect severe acute respiratory syndrome (SARS) patient: Brief technical communication. Can J Surg 2005;48(1):68–71. PMID: 15757043.
  49. Kwan A, Fok WG, Law KI, et al. Tracheostomy in a patient with severe acute respiratory syndrome. Br J Anaesth 2004;92(2):280–282. DOI: 10.1093/bja/aeh035.
  50. Aminnejad R, Salimi A, Saeidi M. Lidocaine during intubation and extubation in patients with coronavirus disease (COVID-19). Can J Anaesth 2020;67(6):759. DOI: 10.1007/s12630-020-01627-2.
  51. Yang SS, Wang NN, Postonogova T, et al. Intravenous lidocaine to prevent postoperative airway complications in adults: A systematic review and meta-analysis. Br J Anaesth 2020;124:314–323. DOI: 10.1016/j.bja.2019.11.033.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.